|
|
Volumn 301, Issue 14, 2009, Pages 1421-1422
|
|
HIV Studies: Progress in microbicides, dead end for an immune-boosting strategy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
BUTTERGEL;
EMTRICITABINE;
INTERLEUKIN 2;
MICROBICIDE;
PLACEBO;
RECOMBINANT INTERLEUKIN 2;
TENOFOVIR;
UNCLASSIFIED DRUG;
AGENTS USED INTRAVAGINALLY;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
IMMUNOLOGIC FACTOR;
NAPHTHALENESULFONIC ACID DERIVATIVE;
POLYMER;
PRO 2000;
CLINICAL RESEARCH;
CLINICAL TRIAL;
CONDOM;
DRUG RESEARCH;
GEL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOTHERAPY;
INFECTION RISK;
NONHUMAN;
PRIORITY JOURNAL;
RISK REDUCTION;
SAFE SEX;
SEMINAL PLASMA;
SHORT SURVEY;
SIMIAN IMMUNODEFICIENCY VIRUS;
VIRUS INFECTION;
AIDS RELATED COMPLEX;
ANIMAL;
FEMALE;
MACACA;
NOTE;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANIMALS;
ANTI-HIV AGENTS;
FEMALE;
HIV INFECTIONS;
HUMANS;
IMMUNOLOGIC FACTORS;
INTERLEUKIN-2;
MACACA;
NAPHTHALENESULFONATES;
POLYMERS;
VAGINAL CREAMS, FOAMS, AND JELLIES;
|
|
EID: 64249131545
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2009.468 Document Type: Short Survey |
|
Times cited : (2)
|
|
References (0)
|